ly 300164 has been researched along with cilengitide in 1 studies
Studies (ly 300164) | Trials (ly 300164) | Recent Studies (post-2010) (ly 300164) | Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) |
---|---|---|---|---|---|
73 | 7 | 12 | 194 | 29 | 133 |
Protein | Taxonomy | ly 300164 (IC50) | cilengitide (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.3087 | |
Integrin beta-1 | Homo sapiens (human) | 1.0131 | |
Integrin alpha-V | Homo sapiens (human) | 0.514 | |
Integrin alpha-IIb | Homo sapiens (human) | 2.399 | |
Integrin alpha-5 | Homo sapiens (human) | 0.9006 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Integrin beta-5 | Homo sapiens (human) | 0.4791 | |
Integrin beta-6 | Homo sapiens (human) | 4.042 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desideri, S; Fisher, J; Grossman, SA; Nabors, LB; Piantadosi, S; Rosenfeld, M; Ye, X | 1 |
1 other study(ies) available for ly 300164 and cilengitide
Article | Year |
---|---|
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Benzodiazepines; Biomedical Research; Brain Neoplasms; Carboxymethylcellulose Sodium; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Drug Therapy, Combination; Female; Glioblastoma; Humans; Interferon Inducers; Male; Middle Aged; Poly I-C; Polylysine; Receptors, AMPA; Snake Venoms; Survival Rate; Temozolomide; Treatment Outcome; United States; Young Adult | 2010 |